Table 2.
Key topics covered by week in the 2020 MEDI 501 course
Week | Topics | Generalizable TS principles |
---|---|---|
Week 1 | • Introduction to translational science • Overview of the case study from drug discovery to development • Description of how the metarrestin project was initiated |
• Address unmet patient needs • Take evidence-informed risks • Pursue major research breakthroughs rather than incremental advances • Use boundary-crossing partnerships |
Week 2 | • Organizational approaches to enable and optimize effective team-based translational research, innovation, and risk-taking • Creativity and innovation, and evidence-informed risk-taking: phenotypic-based drug discovery approaches and high-throughput screening • Optimizing clinical predictability to accelerate research: in vitro assays for drug discovery and development |
• Pursue creativity and innovation • Take evidence-informed risks • Produce cross-cutting solutions • Leverage cross-disciplinary team science • Enhance the efficiency and speed of translational research |
Week 3 | • Cross-disciplinary collaboration with medicinal chemistry to advance preclinical translation research • Optimize medicinal chemistry contributions to advance from drug discovery to drug development |
• Leverage cross-disciplinary team science • Enhance the efficiency and speed of translational research |
Week 4 | • Approaches for successful cross-agency partnerships (government, academia, and industry), including protecting intellectual property and leveraging legal agreements • Strategies for successful cross-disciplinary team-based science for individuals, teams, and organizations |
• Use boundary-crossing partnerships • Leverage cross-disciplinary team science |
Week 5 | • Aligning animal models with clinical needs to enhance research quality and efficiency • Cross-disciplinary collaboration with pharmacology and toxicology to transition from drug discovery to studies that enable filing for an Investigational New Drug (IND) • Addressing unmet patient needs: focus on metastatic pancreatic cancer |
• Address unmet research and patient needs • Leverage cross-disciplinary team science • Enhance the efficiency and speed of translational research |
Week 6 | • Innovation in preclinical translational research: moving from phenotypically driven studies to target identification | • Pursue creativity and innovation • Enhance the efficiency and speed of translational research |
Week 7 | • Regulated clinical trials – goals, design, and implementation • Advancing to first in human clinical trials • Wrap up: case study overview from phenotypic observation to drug development and testing, conclusions, and additional resources |
• Produce cross-cutting solutions • Review all principles demonstrated in this case |